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ABSTRACT Distortion of primary cilium formation is increasingly recognized as a key event 
in many human pathologies. One of the underlying mechanisms involves aberrant activation 
of the lipogenic transcription factor sterol regulatory element–binding protein 1c (SREBP1c), 
as observed in cancer cells. To gain more insight into the molecular pathways by which SREB-
P1c suppresses primary ciliogenesis, we searched for overlap between known ciliogenesis 
regulators and targets of SREBP1. One of the candidate genes that was consistently up-reg-
ulated in cellular models of SREBP1c-induced cilium repression was phospholipase A2 group 
III (PLA2G3), a phospholipase that hydrolyzes the sn-2 position of glycerophospholipids. Use 
of RNA interference and a chemical inhibitor of PLA2G3 rescued SREBP1c-induced cilium 
repression. Cilium repression by SREBP1c and PLA2G3 involved alterations in endosomal re-
cycling and vesicular transport toward the cilium, as revealed by aberrant transferrin and 
Rab11 localization, and was largely mediated by an increase in lysophosphatidylcholine and 
lysophosphatidylethanolamine levels. Together these findings indicate that aberrant activa-
tion of SREBP1c suppresses primary ciliogenesis by PLA2G3-mediated distortion of vesicular 
trafficking and suggest that PLA2G3 is a novel potential target to normalize ciliogenesis in 
SREBP1c-overexpressing cells, including cancer cells.
INTRODUCTION
The primary cilium is a microtubule-based organelle that projects 
from the surface of a wide variety of cells. It acts as an antenna to 
sense extracellular cues and regulates numerous signaling path-
ways such as Hedgehog and Wnt (Christensen et al., 2007; 
Berbari et al., 2009). Defects in primary ciliogenesis are associ-
ated with a wide variety of human diseases. These include ge-
netic disorders called ciliopathies but also many more patholo-
gies, including obesity and cancer, reflecting the importance of 
proper assembly and maintenance of the cilium in developmen-
tal biology and tissue homeostasis (Marshall and Nonaka, 2006; 
Fliegauf et al., 2007). In cancer, loss of the primary cilium is ob-
served in many tumor types (Schraml et al., 2009; Seeley et al., 
2009; Yuan et al., 2010; Kim et al., 2011; Egeberg et al., 2012). It 
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noma cancer cell line, A375. Transfection of this cell line with small 
interfering RNA (siRNA) targeting SREBP1 resulted in 90% knock-
down of SREBP1c mRNA and protein expression (Supplemental 
Figure S1B). This led to significantly increased cilium formation in 
SREBP1-knockdown cells (32%) compared with cells transfected 
with nontargeting siRNA (15%), as revealed by primary cilium stain-
ing with antibodies against acetylated α-tubulin and centrosomal 
marker γ-tubulin (Figure 1B). As expected, we observed a low per-
centage of ciliated cancer cells in the control condition. To corrobo-
rate these findings, we down-regulated endogenous SREBP1 in 
A375 cells using CRISPR/Cas9 technology. Western blot analysis 
showed significant knockdown of SREBP1 in the total pool of cells 
transfected with two independent CRISPR/Cas9 plasmids (Supple-
mental Figure S1C). This led to a significant increase in cilium forma-
tion (nearly 30%) compared with control cells (12%; Figure 1C).
Collectively these results confirm and extend our earlier findings 
that SREBP1c overexpression disturbs primary cilium formation in 
both normal and SREBP1c-overexpressing cancer cells.
Identification of PLA2G3 as a candidate SREBP1c-regulated 
gene affecting ciliogenesis
To identify mediators of SREBP1c-induced cilium repression, we 
searched for SREBP1c targets in a list of previously identified modu-
lators of ciliogenesis selected in a functional genomic screen (Kim 
et al., 2010). From the 36 positive and 13 negative cilium modula-
tors listed, we selected three genes (Figure 2A) that are directly 
regulated by SREBP1 based on existing chromatin immunoprecipi-
tation (ChIP)-chip and microarray data: cyclin-dependent kinase in-
hibitor 2B (CDKN2B), myxovirus resistance 2 (MX2), and PLA2G3 
(Reed et al., 2008). To test whether any of these potential targets of 
SREBP1 is indeed affected by SREBP1c in our ciliogenesis model 
systems, we assessed the expression of the selected genes by qRT-
PCR in mIMCD3, CL4, and MDCK cells infected with adenovirus 
encoding nSREBP1c or with control vector (Figure 2B). nSREBP1c 
differentially affected the expression of these genes in the various 
cell lines. CDKN2B expression was not consistently affected by 
nSREBP1c in all the cell lines and was undetectable in MDCK cells. 
MX2 was differentially affected in the various models. Only the gene 
encoding PLA2G3, a secreted phospholipase A2 enzyme, was con-
sistently activated in all three cell lines. Hence, we selected PLA2G3 
for further investigation.
To establish further the link between SREBP1c activation and 
PLA2G3 expression, we performed the reverse experiment by down-
regulating the endogenous SREBP1 in highly lipogenic A375 mela-
noma cancer cells. Consistent with a role of endogenous SREBP1c in 
the regulation of PLA2G3, siRNA-mediated knockdown of SREBP1c 
resulted in a 40% decrease in PLA2G3 expression (Figure 2C).
PLA2G3 is a direct target of SREBP1c
The ChIP-chip data mentioned earlier (Reed et al., 2008) suggest 
that PLA2G3 is a direct target of SREBP1c. In addition, analysis of 
ChIP-sequencing (seq) data in the ENCODE project (Bernstein 
et al., 2012) showed SREBP1 occupation at the promoter of PLA2G3 
(Figure 3A). Of importance, the potential SREBP1-binding site iden-
tified in these ChIP studies (referred to as SRE-1) is conserved in the 
PLA2G3 promoter region of all four species from which the cell lines 
we use in this study are derived (mouse, pig, dog, and human; 
Figure 3B). To confirm binding of nSREBP1c to the PLA2G3 gene in 
our models, we performed ChIP experiments with MDCK and 
mIMCD3 cells infected with adenovirus encoding nSREBP1c or con-
trol virus. qRT-PCR analysis using primers flanking the SRE-1 motif in 
the promoter of PLA2G3 showed significantly increased signal upon 
reflects the inability of cancer cells to exit the cell cycle (Plotnikova 
et al., 2008).
Previous work by our team showed that aberrant activation of 
the lipogenic transcription factor sterol regulatory element-binding 
protein 1c (SREBP1c) plays a key role in the loss of the primary cilium 
in cancer cells (Willemarck et al., 2010). SREBP1c is a helix-loop-he-
lix leucine zipper transcription factor that modulates the expression 
of a wide array of enzymes involved in fatty acid synthesis. SREBP1c 
is synthesized as inactive precursor inserted into the endoplasmic 
reticulum membrane, where it binds to the SREBP cleavage activat-
ing protein (SCAP). To activate transcription, SREBP1c/SCAP com-
plex translocates to the Golgi, where a two-step proteolytic cleav-
age releases the NH2-terminal domain of SREBP1c. This mature 
form can enter the nucleus and bind to sterol regulatory elements 
(SREs) within the promoter of its target genes (Brown and Goldstein, 
1997; Horton et al., 2002). SREBP1c plays a key role in energy ho-
meostasis and seems to be involved in lipid metabolism in cancer 
cells (Menendez and Lupu, 2007). Here SREBP1c is often overacti-
vated by constitutive growth factor signaling and plays a key role in 
the cellular adaptation of lipid metabolism to the increased lipid 
demand and changing environmental conditions (Swinnen et al., 
2000; Griffiths et al., 2013).
In this study, we sought to pinpoint the mechanism by which 
SREBP1c suppresses primary ciliogenesis. We identified phospholi-
pase A2 group III (PLA2G3) as one of the prime mediators. PLA2G3 
is a secreted phospholipase that hydrolyzes glycerophospholipids 
at the sn-2 position, resulting in the generation of lysophospholipids 
and the release of free fatty acids. The present study implicates 
PLA2G3 in the cilium-repressing action of SREBP1c by modulating 
vesicular trafficking and reveals significant novel insights in the 
mechanism of primary cilium suppression in SREBP1c-overexpress-
ing cells, including some cancer cells.
RESULTS
Aberrant SREBP1c expression impairs primary cilium 
formation in multiple cell line models
Previous research by our team revealed that aberrant expression of 
the mature nuclear form of human SREBP1c (nSREBP1c) distorts pri-
mary cilium formation in Xenopus embryos and Madin–Darby ca-
nine kidney (MDCK) cells (Willemarck et al., 2010). To consolidate 
this concept, we now expand these findings to other well-ciliated 
cell line models from different species, including murine inner med-
ullary collecting duct (mIMCD3) and porcine kidney (CL4) cells, 
which are commonly used to study ciliogenesis. To this end, cells 
were infected with adenovirus encoding nSREBP1c or control virus. 
nSREBP1c functionality was confirmed with quantitative real time re-
verse transcription PCR (qRT-PCR) and Western blot analysis for fatty 
acid synthase (FASN) expression, a known target gene of nSREBP1c 
(Supplemental Figure S1A). After reaching confluency, primary cilia 
were visualized by immunocytochemical staining for axonemal 
marker acetylated α-tubulin (Figure 1A). Control mIMCD3 cells dis-
played cilia on 83% of the cells, whereas nSREBP1c transduction 
significantly decreased the percentage of ciliated cells to 37%. Simi-
larly, in CL4 cells, ectopic nSREBP1c expression resulted in a signifi-
cantly decreased ciliogenesis, from 81% to 42%. Similar deficits in 
ciliogenesis were observed in nSREBP1c-transfected MDCK cells, as 
previously described (Willemarck et al., 2010). In all three cell lines, 
nSREBP1c transduction resulted in a flattening and enlargement of 
the cells, as previously described (Willemarck et al., 2010).
We also performed the converse experiment. Because SREBP1c 
is constitutively activated in many cancer cells, we down-regulated 
endogenous SREBP1 in a highly lipogenic human malignant mela-
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FIGURE 1: Modulation of SREBP1c expression affects primary cilium formation in various cell line models. (A) Ectopic 
nSREBP1c expression in well-ciliated, nonmalignant cells decreases primary cilium formation. mIMCD3, CL4, and MDCK 
cells were infected with nSREBP1c or control adenovirus. Primary cilia were visualized by immunofluorescence staining 
of acetylated α-tubulin (red). Nuclei were stained with DAPI (blue). For quantification, 500–900 cells were scored. 
(B, C) SREBP1 knockdown stimulates ciliogenesis in lipogenic cancer cells. A375 cells were transfected with 
nontargeting (siNT) or SREBP1-targeting siRNA (siSREBP1; B) or with SREBP1-targeting CRISPR/Cas9 plasmids (C). Cells 
were stained for acetylated α-tubulin (red), γ-tubulin (green), and DAPI (blue). For quantification, 700–800 cells were 
scored. Insets, magnification of a representative region. Left, representative pictures of three independent experiments. 
Bar, 20 μM. Right, percentage of ciliated cells. Error bars, SEM. **p < 0.005 and ***p < 0.0005 using Student’s t test.
2324 | H. L. Gijs et al. Molecular Biology of the Cell
PLA2 family members (PLA2G1b, PLA2G2a, PLA2G2c, PLA2G2d, 
PLA2G2e, PLA2G2f, PLA2G5, PLA2G10, PLA2G12a, PLA2G12b). 
Acetylated α-tubulin staining revealed that PLA2G3 knockdown res-
cued ciliogenesis in nSREBP1c-transfected mIMCD3 cells (Figure 4, 
A and B). To corroborate these findings, we attenuated PLA2G3 
activity using oleyloxyethyl phosphorylcholine (OPC), an inhibitor of 
secreted phospholipase A2. In line with the knockdown experiment, 
OPC treatment restored cilium formation in nSREBP1c-transduced 
mIMCD3 and MDCK cells in a dose-dependent manner (Figure 4C). 
Moreover, siRNA-mediated knockdown of PLA2G3 in lipogenic 
melanoma A375 cells using two different siRNAs causing 70 and 
75% knockdown of PLA2G3 (Supplemental Figure S2B) stimulated 
ciliogenesis (Figure 4D). An alignment study of these human 
PLA2G3 siRNAs showed no off-target effects toward other secreted 
PLA2 family members. A similar increase in ciliogenesis was ob-
served after treatment of A375 cells with OPC (Figure 4D).
Taken together, these data suggest that primary cilium suppres-
sion observed in SREBP1c-overexpressing cells results from in-
creased PLA2G3 expression.
PLA2G3 mediates SREBP1c-induced cilium repression 
by disturbing vesicle trafficking
Willemarck et al. (2010) observed that ectopic nSREBP1c expression 
in MDCK cells results in mislocalization of apical markers (gp114/
CEA and g135/podocalyxin) and defects in cyst formation. These 
findings suggest that SREBP1c expression affects apical protein 
transport and cell polarization. Given also that PLA2G3 has been 
nSREBP1c expression, indicative of nSREBP1c binding directly to 
the promoter of PLA2G3 in MDCK cells. A similar trend was ob-
served in mIMCD3 cells (Figure 3C).
To determine the importance of this site in the transcriptional 
regulation of PLA2G3 by SREBP1c, we performed a promoter lucif-
erase report assay with human PLA2G3 promoter-based constructs 
containing the wild-type, mutated, or deleted SRE-1 binding site 
(Figure 3D). On cotransfection with SREBP1c-encoding plasmid in 
HEK cells, increased luciferase activity was measured for the wild-
type promoter construct. Significantly less activation was observed 
for the promoter construct with mutated SRE-1 site, and no in-
creased activity was measured for the deleted-SRE-1 promoter con-
struct (Figure 3E).
Taken together, these data indicate that nSREBP1c interacts with 
the SRE-1 binding site in the promoter of PLA2G3 and regulates 
PLA2G3 gene expression.
PLA2G3 acts as mediator of SREBP1c-induced cilium 
repression
To explore the role of PLA2G3 in SREBP1c-induced cilium repres-
sion, we attenuated PLA2G3 induction by nSREBP1c using siRNA-
mediated knockdown in mIMCD3 cells and assessed the affect on 
ciliogenesis. When analyzed by qRT-PCR, knockdown of PLA2G3 
using two different siRNAs reduced PLA2G3 expression in 
nSREBP1c-transduced cells to nearly basal levels observed in con-
trol cells (Supplemental Figure S2A). An alignment study for these 
mouse PLA2G3 siRNAs showed no specificity for other secreted 
FIGURE 2: Identification of PLA2G3 as candidate gene mediating nSREBP1c-induced cilium repression. (A) Venn diagram 
of known cilium modulators and direct SREBP1 targets. (B) qRT-PCR analysis of CDKN2B, MX2, and PLA2G3 in mIMCD3, 
CL4, and MDCK cells 48 h after infection with adenovirus encoding nSREBP1c versus control vector. ND, nondetectable. 
(C) qRT-PCR analysis of SREBP1c and PLA2G3 in A375 cells 48 h after transfection with SREBP1 siRNA (siSREBP1) or 
nontargeting siRNA (siNT). N = 3; error bars, SEM. **p < 0.005 and ***p < 0.0005 using Student’s t test.
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vesicles were found in the cytosol. More vesicles accumulated ab-
normally after 30 and 60 min of continuous Alexa 564–transferrin 
uptake in nSREBP1c-transduced cells, providing evidence that recy-
cling of the transferrin receptor to the plasma membrane is impaired 
in cells with aberrant nSREBP1c expression (Figure 5A and Supple-
mental Figure S3A). This was not due to a reduction of the transfer-
rin receptor at the protein level, as the total amount was comparable 
in control and nSREBP1c-transduced cells (Supplemental Figure 
S3B). Staining for the early endosomal antigen-1 (EEA1) showed 
that transferrin accumulates in the early endosomal compartment. 
When SREBP1c-transduced cells were transfected with siRNAs 
targeting PLA2G3, transferrin accumulation was no longer observed 
implicated in endocytic recycling pathway (Kim et al., 2010) and be-
cause this process plays a key role in ciliogenesis (Hsiao et al., 2012), 
we hypothesized that PLA2G3 mediates nSREBP1c-induced cilium 
repression by disturbing vesicular trafficking necessary for cilium for-
mation. To test this hypothesis, we assessed intracellular vesicular 
trafficking by analyzing the uptake and recycling of fluorescently la-
beled transferrin at different time points in control and nSREBP1c-
transduced mIMCD3 cells. Transferrin was normally internalized in 
both control and nSREBP1c-transduced cells after 5 min of continu-
ous uptake. However, after 15 min of transferrin uptake, cells over-
expressing nSREBP1c enriched transferrin vesicles in a perinuclear 
compartment in contrast to control cells, in which transferrin-positive 
FIGURE 3: Identification of cilium modulator PLA2G3 as direct target of SREBP1c. (A) ChIP-seq analysis from ENCODE 
showing SREBP1 binding (pink peak) on the promoter of PLA2G3 (blue) in HEPG2 cells. The black arrow indicates the 
position of the SRE-1 binding site. (B) Alignment of the PLA2G3 promoter region of four species (human, mouse, pig, 
and dog) showing that the SRE-1 binding site (CACCCCAT) is conserved. (C) ChIP analysis of nSREBP1 binding to the 
SRE-1 binding site in the promoter of PLA2G3 in MDCK and mIMCD3 cells. The well-known SREBP1c target gene, 
FASN, was used as a reference. (D) Overview of PLA2G3 promoter-reporter constructs containing wild-type (WT), 
mutated (mut), or deleted (del) SRE-1 binding site. (E) Luciferase assay of WT, mut, and del PLA2G3 promoter-reporter 
constructs in HEK-293 cells 24 h after transfection together with control or SREBP1c plasmid, using β-galactosidase for 
normalization. N = 3; error bars, SEM. *p < 0.05 and ***p < 0.0005 using Student’s t test.
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We also explored the localization of the endosomal-recycling 
marker Rab11. This Rab GTPase localizes at the ciliary base and 
regulates vesicle trafficking during ciliogenesis (Knodler et al., 2010; 
Westlake et al., 2011). Figure 6 shows that Rab11 is enriched at the 
base of the cilium around the centrosome in control mIMCD3 cells, 
whereas it is dispersed more diffusely in the cytoplasm in cells 
after 30 min in the early endosomal compartment (Figure 5B), dem-
onstrating that defects in transferrin trafficking could be rescued by 
attenuation of PLA2G3 expression in cells overexpressing nSREBP1c. 
This was confirmed by calculating the Pearson correlation coeffi-
cient, which describes the colocalization of transferrin and EEA1-
positive vesicles (Figure 5C).
FIGURE 4: Involvement of PLA2G3 in SREBP1c-induced cilium repression. (A, B) Knockdown of PLA2G3 attenuates 
SREBP1c-induced cilium repression in nonmalignant cells. mIMCD3 cells were infected with control or nSREBP1c 
adenovirus in combination with PLA2G3-targeting siRNA (siPLA2G3) or nontargeting siRNA (siNT). Cells were stained 
for acetylated α-tubulin (red) and DAPI (blue). Representative pictures of two independent experiments. Bar, 20 μM. For 
quantification, 250–450 cells were scored. (C) Chemical inhibition of PLA2G3 attenuates SREBP1c-induced cilium 
repression in nonmalignant cells. mIMCD3 and MDCK cells were infected with control or nSREBP1c adenovirus and 
treated with different concentrations of OPC for 32 h. From 400 to 1000 cells were scored. (D) Knockdown or inhibition 
of PLA2G3 stimulates ciliogenesis in A375 cells. Cells were transfected with siPLA2G3 or treated with 5 μM OPC for 
32 h. Cells were stained for acetylated α-tubulin (red), γ-tubulin (green), and DAPI (blue). Representative pictures of 
three independent experiments (bar, 20 μM). Insets, magnification of representative regions. For quantification, 
600–900 cells were scored. N = 3; error bars, SEM. *p < 0.05, **p < 0.005, and ***p < 0.0005 using Student’s t test.
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Involvement of lysophospholipids in nSREBP1c- 
and PLA2G3-induced cilium repression
To assess further how nSREBP1c-induced PLA2G3 can suppress cil-
iogenesis, we determined the role of lysophospholipid formation by 
PLA2G3 in primary cilium formation. In fact, together with free fatty 
acids, lysophospholipids are the main direct end products of 
overexpressing nSREBP1c. In addition, these changes cannot be ex-
plained by differences in total amount of Rab11 at the protein level 
(Supplemental Figure S3B). These changes in vesicle transport were 
rescued when PLA2G3 expression was normalized using siRNAs.
Overall these results indicate that PLA2G3 affects vesicle traffick-
ing to the plasma membrane in nSREBP1c-transduced cells.
FIGURE 5: PLA2G3 mediates impaired transferrin recycling induced by SREBP1c. (A) SREBP1c-overexpressing cells 
accumulate transferrin in a perinuclear region. mIMCD3 cells were infected with nSREBP1c or control adenovirus. Cells 
were fixed after 5, 15, 30, and 60 min of Alexa Fluor 564–conjugated transferrin uptake (red) and stained with DAPI 
(blue). N = 3. Bar, 10 μM. Magnification of representative regions from Supplemental Figure S3A are shown. (B) PLA2G3 
mediates aberrant transferrin accumulation in early endosomes upon SREBP1c transduction. mIMCD3 cells were 
infected with control or nSREBP1c adenovirus in combination with PLA2G3-targeting siRNA (siPLA2G3) or nontargeting 
siRNA (siNT). Cells were fixed after 30 min of Alexa Fluor 564–conjugated transferrin uptake (red) and stained for EEA1 
(green) and DAPI (blue). N = 3. (C) Quantification of transferrin receptor colocalization with EEA1 expressed by 
Pearson’s coefficient. N = 15; error bars, SEM. ***p < 0.0005 using Student’s t test.
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dylinositol and lysophosphatidylserine spe-
cies (Supplemental Figure S4B).
To elucidate further the role of increased 
lysophospholipid levels in cilium distortion 
in nSREBP1c-transduced cells, we treated 
mIMCD3 cells with LPC 18:1, one of the 
most abundant lysophospholipid species 
up-regulated by nSREBP1c (Supplemental 
Figure S4A), and visualized primary cilia us-
ing acetylated α-tubulin staining. We ob-
served a significant and dose-dependent 
reduction of ciliogenesis after treatment 
with LPC 18:1 (Figure 7B). Similar treatments 
with free fatty acids evoked only minor ef-
fects (Supplemental Figure S4C).
These results indicate that PLA2G3-in-
duced up-regulation of LPC and LPE levels 
at least partially mediates the distortion of 
primary cilium formation by nSREBP1c.
DISCUSSION
Defects in primary cilia formation are 
increasingly recognized as a central event 
in many human pathologies, including 
classical ciliopathies, obesity, and cancer 
(Fliegauf et al., 2007; Sen Gupta et al., 2009; 
Basten and Giles, 2013). Recently our team 
found that the lipogenic transcription factor 
SREBP1c, which is aberrantly activated in 
several of these diseases, plays an impor-
tant role as mediator in the observed cilium 
repression (Willemarck et al., 2010). Here 
we show that the nSREBP1c-induced cilium 
repression is a more general phenomenon, 
which we observe in mammalian cell lines of 
different origin and in a human melanoma 
cancer cell line. To gain more insight into 
the molecular mechanisms by which 
SREBP1c suppresses primary ciliogenesis, 
we searched for SREBP1 targets in a list of 
known ciliogenesis modulator genes and 
identified PLA2G3 as a prime candidate.
PLA2G3 belongs to the subgroup of se-
creted phospholipase A2 and was previously 
implicated in cilium formation (Kim et al., 
2010). Based on existing ChIP-chip and 
ChIP-seq data, complemented by our ChIP 
and promoter-reporter studies, we identi-
fied PLA2G3 as a direct target of SREBP1c. 
By modulating the expression of PLA2G3 in 
a highly selective way by siRNA or by more 
general chemical inhibition of phospholi-
pase A2 activity in well-ciliated normal cells as well as in highly lipo-
genic cancer cells, we demonstrated that PLA2G3 indeed functions 
as a key mediator of SREBP1c-induced cilium repression. Consistent 
with our earlier findings that nSREBP1c expression results in mislo-
calization of apical markers (Willemarck et al., 2010) and that 
PLA2G3 may affect vesicle trafficking (Kim et al., 2010), we show 
here that PLA2G3 mediates the cilium repressing effect of SREBP1c 
by affecting vesicle trafficking. Vesicle trafficking is a process that 
has been implicated in ciliogenesis in several studies (Leroux, 2007; 
Emmer et al., 2010; Hsiao et al., 2012). In the present study, we 
PLA2G3 and have the ability to affect vesicle formation by changing 
membrane curvature (Brown et al., 2003). We analyzed the lyso-
phospholipid content of mIMCD3 cells using a targeted mass spec-
trometry method. nSREBP1c transduction dramatically increased all 
major lysophosphatidylcholine (LPC) and lysophosphatidylethanol-
amine (LPE) species (Figure 7A and Supplemental Figure S4A). 
When nSREBP1c-transduced cells were transfected with PLA2G3 
targeting siRNAs, LPC and LPE contents were reduced to the basal 
levels of control cells (Figure 7A and Supplemental Figure S4A). We 
observed no significant changes in the levels of lysophosphati-
FIGURE 6: PLA2G3 mediates impaired Rab11 ciliary vesicle trafficking induced by SREBP1c. 
(A) Rab11 trafficking to the base of the cilium is disturbed by nSREBP1c-induced PLA2G3. 
mIMCD3 cells were infected with control or nSREBP1c adenovirus in combination with PLA2G3-
targeting siRNA (siPLA2G3) or nontargeting siRNA (siNT). Cells were stained for rab11 (green), 
acetylated α-tubulin (red), and DAPI (blue). N = 3 (bar, 20 μM). Bottom, side view of Z-stack 
projection. (B) nSREBP1c-induced PLA2G3 disturbs Rab11 accumulation around the centrosome. 
mIMCD3 cells were treated as in A. Cells were stained for rab11 (green), γ-tubulin (red), and 
DAPI (blue). Bar, 10 μM. Bottom, side view of Z-stack projection.
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showing that lysophospholipids affect the membrane curvature 
(Brown et al., 2003).
On the basis of these findings, we propose the following mecha-
nistic model through which SREBP1 affects ciliogenesis in cancer 
cells. In nonmalignant cells, which show low levels of nuclear 
SREBP1, Rab11-positive vesicles traffic to the pericentrosomal pre-
ciliary compartment (PPC) associated with the centrosome (Kim 
et al., 2010) and later to the base of the forming cilium to deliver 
cargo required for ciliogenesis (Figure 8A). In contrast, in cancer cells 
that aberrantly express the lipogenic transcription factor SREBP1c, 
PLA2G3 gets overexpressed through direct transcriptional regula-
tion (Figure 8B). On secretion, PLA2G3 may act on extracellular 
phospholipids of the plasma membrane, and/or on intracellular 
phospholipids during the secretion process or upon endocytosis, 
and/or upon sequestration at the centrosome/centriole pair (Kim 
et al., 2010). The increase in LPCs resulting from the hydrolysis of 
phosphatidtylcholines (PCs) increases the positive membrane curva-
ture in the plasma membrane and intracellular (vesicle) membranes 
showed that SREBP1c overexpression affected transferrin transport 
and led to a mislocalization of the recycling marker Rab11, which 
normally localizes to the perinuclear recycling compartment in prox-
imity of the ciliary base and regulates vesicle trafficking during cilio-
genesis (Knodler et al., 2010; Westlake et al., 2011). Modulation of 
PLA2G3 expression confirmed that these effects were mediated by 
this phospholipase.
As a secreted phospholipase, PLA2G3 hydrolyses the sn-2 posi-
tion of glycerophospholipids, resulting in the release of a free fatty 
acid and a lysophospholipid in the outer leaflet of the plasma mem-
brane or in the secretory and endocytotic vesicles inside the cell 
during its own secretion and subsequent internalization (Murakami 
et al., 2003). We showed that SREBP1c induces large levels of LPC 
and LPE, which, consistent with the localization of PLA2G3, are typi-
cally generated at the outer membrane leaflet. Mimicking the in-
crease of these lipids by exogenous supplementation represses cil-
ium formation, implying a role of these lipids in the cilium-repressing 
effects of SREBP1c. This finding is consistent with previous studies 
FIGURE 7: PLA2G3 mediates SREBP1c-induced suppression of ciliogenesis through formation of lysophospholipids. 
(A) nSREBP1c-induced PLA2G3 expression increases LPC and LPE levels. mIMCD3 cells were infected with control or 
nSREBP1c adenovirus in combination with PLA2G3-targeting siRNA (siPLA2G3) or nontargeting siRNA (siNT). 
Lysophospholipids were measured by electrospray tandem mass spectrometry after 72 h. Data are expressed as the 
sum of all measured individual LPC and LPE species, respectively. (B) LPC 18:1 treatment suppresses ciliogenesis. 
mIMCD3 cells were treated with different concentrations of LPC 18:1 for 72 h and stained for acetylated α-tubulin (red) 
and DAPI (blue). Representative pictures of two independent experiments. Bar, 20 μM. For quantification, 650–750 cells 
were scored. N = 3; error bars, SEM. *p < 0.05, **p < 0.005, and ***p < 0.0005 using Student’s t test.
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MDCK and A375 cells were grown to confluency, followed by an 
additional 5 d in serum-deprived medium, whereas mIMCD3 and 
CL4 cells were grown for an additional 2 d after confluency in the 
same medium. To ectopically express nSREBP1c, cells were infected 
on day 1 with 10 plaque-forming units (pfu)/cell (CL4), 30 pfu/cell 
(MDCK), or 50 pfu/cell (mIMCD3) of adenovirus encoding the first 
403 amino acids of human SREBP1c or enhanced GFP as a control 
(kindly provided by F. Foufelle, Université Paris, Paris, France; Foretz 
et al., 1999). mIMCD3 cells were reverse transfected with 5 nM ON-
TARGETplus siRNA targeting PLA2G3 or nontargeting siRNA (Am-
bion) using Lipofectamine RNAiMAX (Life Technologies) according 
to the manufacturer’s reverse transfection protocol. To inhibit 
PLA2G3 activity, MDCK and mIMCD3 cells were treated with differ-
ent concentrations of OPC (Cayman Chemicals, Ann Arbor, MI) dis-
solved in ethanol in the presence of 10% serum during 32 h before 
fixation. A375 cells were transfected with ON-TARGETplus siRNA 
targeting SREBP1 (1 nM), PLA2G3 (5 nM), or nontargeting siRNA 
(Dharmacon, Lafayette, CO) using Lipofectamine RNAiMAX. SiRNA 
sequences are provided in Supplemental Table S1. SREBP1 CRISPR/
Cas9 plasmids (Sigma-Aldrich) targeting the first exon were trans-
fected into A375 cells using FuGENE (Promega, Madison, WI) ac-
cording to the supplier’s protocol. One day posttransfection, GFP-
positive, propidium iodide–negative cells were sorted using a 
FACSAria III (BD Biosciences, San Jose, CA) for further analysis. 
and causes Rab11-positive vesicles to deviate away from the PPC 
and the base of the cilium, resulting in the suppression of cilium 
formation in SREBP1c-overexpressing cells (Figure 8B).
Together with findings that PLA2G3 is often overexpressed in 
lipogenic cancer types such as uterus, colon, and breast cancer 
(Murakami et al., 2005; Mounier et al., 2008; Brglez V, 2014), which 
also often show cilium loss (Yuan et al., 2010; Menzl et al., 2014), our 
findings provide significant novel insights into the mechanism by 
which the primary cilium gets lost in those human cancers character-
ized by SREBP1c overexpression. In view of the important role that 
primary cilia play in these diseases, our observations warrant further 
investigation into the role of SREBP1c and more specifically PLA2G3 
as potential targets for novel therapeutic approaches aimed at re-
storing ciliogenesis.
MATERIALS AND METHODS
Cell culture and reagents
MDCK, mIMCD3, CL4, A375, and HEK-293 cells were purchased 
from the American Type Culture Collection (Manassas, VA). mIMCD3 
and MDCK cells were cultured in DMEM/F12 (Life Technologies, 
Grand Island, NY), CL4 was grown in MEMα (Life Technologies), and 
HEK-293 cells were maintained in DMEM (Life Technologies), all 
supplemented with 10% fetal calf serum (Life Technologies) at 37°C 
in a humidified atmosphere of 5% CO2. To induce ciliogenesis, 
FIGURE 8: Mechanistic model through which nSREBP1c mediates cilium suppression. (A) In cells with low expression of 
mature nSREBP1, Rab11-positive transport vesicles deliver cargo at the PPC/base of the cilium. (B) In cells with 
increased nSREBP1 expression, nSREBP1c activates the transcription of PLA2G3, which, upon secretion, (i) hydrolyzes 
PC to produce LPC, which may act extracellularly (ii) and/or intracellularly after internalization (iii). Concomitantly, 
PLA2G3 may act intracellularly during the secretion process (i), upon reinternalization (iv), and/or upon sequestration at 
the centrosome/centriole pair (v). LPC may distort ciliogenesis by affecting membrane curvature (vi) and by causing 
Rab11-positive cargo to deviate away from the PPC or the base of the cilium (vii).
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(Sigma-Aldrich), γ-tubulin (Sigma-Aldrich), EEA1 (Sigma-Aldrich), 
Rab11 (US Biologicals), and Alexa Fluor–conjugated secondary anti-
bodies (Life Technologies). To study transferrin uptake, mIMCD3 
cells were washed in serum-free medium and incubated in the same 
medium with Alexa Fluor 546–conjugated transferrin (Life Technolo-
gies) at 37°C, followed by fixation in paraformaldehyde. Images and 
Z-stack shots were acquired on an Olympus FluoView FV1000 con-
focal laser scanning microscope using an oil immersion UPLSAPO 
60×/1.35 numerical aperture (Olympus, Tokyo, Japan) objective 
with associated software (FV10-ASW). The Z-step size was 1 μM. 
ImageJ software (National Institutes of Health, Bethesda, MD) was 
used to process images and quantify cilia. Cilia frequency was deter-
mined by counting cilia per cell. A primary cilium was considered if 
the long acetylated α-tubulin structure was attached to a γ-tubulin 
spot (acetylated α-tubulin plus γ-tubulin staining) or a long acety-
lated α-tubulin structure near a nucleus (acetylated α-tubulin and 
4′,6-diamidino-2-phenylindole [DAPI] staining).
Analysis of lysophospholipid species by electrospray 
ionization tandem mass spectrometry
Lysophospholipids were analyzed by a targeted multiple reaction 
monitoring–based mass spectrometry method. Lipids were extracted 
by homogenizing cells in 1 N HCl/CH3OH (1:8 [vol/vol]), CHCl3, and 
200 μg/ml antioxidant 2,6-di-tert-butyl-4-methylphenol (Sigma-Al-
drich). Lysophospholipid standards were added based on the amount 
of DNA in the original sample (LPC 13:0 [31.98 nmol/mg DNA], LPC 
17:1 [29.025 nmol/mg DNA], LPE 13:0 [36.4547 nmol/mg DNA], LPE 
17:1 [32.2193 nmol/mg DNA], lysophosphatidylserine [LPS] 13:0 
[31.4162 nmol/mg DNA], LPS 17:1 [32.2193 nmol/mg DNA], lyso-
phosphatidylinositol [LPI] 13:0 [27.3938 nmol/mg DNA], and LPI 17:1 
[24.931 nmol/mg DNA]). The organic fractions were evaporated and 
reconstituted in CH3OH/CHCl3/NH4OH (90:10:1.25 [vol/vol/vol]). 
Phospholipids were analyzed by electrospray ionization tandem mass 
spectrometry on a hybrid quadrupole linear ion trap mass spectrom-
eter (4000 QTRAP system; Applied Biosystems) equipped with a 
robotic nanoflow/ion source (Advion Biosciences, Ithaca, NY). The 
system was operated in the multiple reaction monitoring mode for 
quantification of individual species. Data were corrected for 13C iso-
tope effects.
mIMCD3 cells were treated with lysophospholipids (LPC 18:1; 
Avanti Polar Lipids) or arachidonic acid (Sigma-Aldrich) for 72 h.
qRT-PCR analysis
RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, 
Germany), and cDNA was prepared with Goscript Reverse Tran-
scription (Promega) according to the manufacturer’s protocol. qRT-
PCR analysis was performed on a 7500 Fast Real-Time PCR system 
(Applied Biosystems, Foster City, CA). Ct values were normalized to 
18S and expressed relative to the control condition. Primer se-
quences are provided in Supplemental Table S1.
Western blot analysis
Equal amounts of protein were loaded onto precast gels (NuPAGE; 
Life Technologies), transferred to nitrocellulose membranes, and in-
cubated with antibodies against SREBP1 (Active Motif, Carlsbad, 
CA), FASN (Van de Sande et al., 2002), Rab11 (US Biological, Salem, 
MA), transferrin receptor (Zymed Laboratories, San Francisco, CA), 
α-tubulin (Cell Signaling Technology, Danvers, MA), and β-actin 
(Sigma-Aldrich), as described in Rysman et al. (2010).
ChIP-seq analysis in ENCODE
The presence of SREBP1 the ChIP peaks around the PLA2G3 tran-
scription start site was analyzed using the data set HEPG2 SREBP1 
Standard insulin ChIP-seq Signal from ENCODE/SYDH, available 
in the ENCODE project (Bernstein et al., 2012), with GSM935627 
as the GEO sample accession number.
ChIP
ChIP was performed using the ChIP-IT Express Chromatin Immuno-
precipitation Kit (Active Motif) according to the manufacturer’s proto-
col. Protein–DNA complexes in MDCK and mIMCD3 cells were fixed 
by paraformaldehyde for 10 min at room temperature. Chromatin 
was sonicated with an ultrasonic processor (UP50H; Hielscher, Teltow, 
Germany) by repeated submaximal bursts with intermittent cooling 
on ice. Samples were immunoprecipitated overnight at 4°C with an-
tibody against SREBP1 (Santa Cruz Biotechnology, Dallas, TX), RNA 
polymerase, or mouse immunoglobulin G (control kit; Active Motif) 
or no antibody, in combination with protein G magnetic beads. Anti-
body–chromatin complexes were eluted, and DNA was extracted 
(Qiagen MiniElute PCR Purification Sit) for qRT-PCR analysis. Primer 
sequences are provided in Supplemental Table S1.
Luciferase reporter assay
A PLA2G3 promoter-luciferase construct was obtained from Switch-
gear Genomics (Menlo Park, CA; s707075). Derivatives harboring a 
triple point mutation in the first SRE-binding site of the promoter 
(CACCCCAT → CACCGATT) or a deletion of the first SRE-binding 
site (Smith et al., 1990) were generated using the QuikChange Site 
Directed Mutagenesis Kit (Stratagene, La Jolla, CA). HEK-293 cells 
were cotransfected with the appropriate promoter construct (100 ng), 
an expression construct encoding SREBP-1c (pIRES-SREBP1c), or 
control plasmid (pIRES-NEO; 10 ng) and β-galactosidase expression 
plasmid (Stratagene; 10 ng) using FuGENE HD Transfection Reagent 
(Roche, Basel, Switzerland). At 24 h posttransfection, whole-cell ly-
sates were analyzed using a firefly luciferase assay system (Promega) 
and normalized for β-galactosidase (Applied Biosystems).
Immunofluorescence
Cells were grown on coverslips and fixed 4 or 7 d postseeding for 
20 min in 3.7% paraformaldehyde. Coverslips and paraffin sections 
were stained with primary antibodies against acetylated α-tubulin 
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